Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies

Xuan Ru Ji, Kuan Chung Cheng, Yu Ru Chen, Tzu Yu Lin, Chun-Hei Cheung, Chia Lin Wu, HsuehCheng Chinag

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal ofmisfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated β-amyloid (Ab) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of Ab peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric β-amyloid42 (Aβ42), while autophagy and UPS clear oligomeric Aβ42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased Aβ42 clearance, it reduced the life span of Aβ42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced Aβ42- induced learning and memory deficits, but there was no effect on Aβ42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles inthe removal ofAβ42 aggregates andindisease progression.These findings alsosuggest thatpharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.

Original languageEnglish
Pages (from-to)1375-1387
Number of pages13
JournalFASEB Journal
Volume32
Issue number3
DOIs
Publication statusPublished - 2018 Mar 1

Fingerprint

Autophagy
Pathology
Proteasome Endopeptidase Complex
Ubiquitin
Alzheimer Disease
Degradation
Peptides
Optical Imaging
Memory Disorders
Amyloid
Diptera
Brain
Proteins
Fluorescence
Learning
Imaging techniques
Data storage equipment
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Ji, Xuan Ru ; Cheng, Kuan Chung ; Chen, Yu Ru ; Lin, Tzu Yu ; Cheung, Chun-Hei ; Wu, Chia Lin ; Chinag, HsuehCheng. / Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies. In: FASEB Journal. 2018 ; Vol. 32, No. 3. pp. 1375-1387.
@article{521da52f3d8047cf9bdf2da033ddba34,
title = "Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies",
abstract = "The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal ofmisfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated β-amyloid (Ab) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of Ab peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric β-amyloid42 (Aβ42), while autophagy and UPS clear oligomeric Aβ42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased Aβ42 clearance, it reduced the life span of Aβ42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced Aβ42- induced learning and memory deficits, but there was no effect on Aβ42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles inthe removal ofAβ42 aggregates andindisease progression.These findings alsosuggest thatpharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.",
author = "Ji, {Xuan Ru} and Cheng, {Kuan Chung} and Chen, {Yu Ru} and Lin, {Tzu Yu} and Chun-Hei Cheung and Wu, {Chia Lin} and HsuehCheng Chinag",
year = "2018",
month = "3",
day = "1",
doi = "10.1096/fj.201700199RR",
language = "English",
volume = "32",
pages = "1375--1387",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies. / Ji, Xuan Ru; Cheng, Kuan Chung; Chen, Yu Ru; Lin, Tzu Yu; Cheung, Chun-Hei; Wu, Chia Lin; Chinag, HsuehCheng.

In: FASEB Journal, Vol. 32, No. 3, 01.03.2018, p. 1375-1387.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dysfunction of different cellular degradation pathways contributes to specific β-amyloid42-induced pathologies

AU - Ji, Xuan Ru

AU - Cheng, Kuan Chung

AU - Chen, Yu Ru

AU - Lin, Tzu Yu

AU - Cheung, Chun-Hei

AU - Wu, Chia Lin

AU - Chinag, HsuehCheng

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal ofmisfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated β-amyloid (Ab) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of Ab peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric β-amyloid42 (Aβ42), while autophagy and UPS clear oligomeric Aβ42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased Aβ42 clearance, it reduced the life span of Aβ42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced Aβ42- induced learning and memory deficits, but there was no effect on Aβ42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles inthe removal ofAβ42 aggregates andindisease progression.These findings alsosuggest thatpharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.

AB - The endosomal-lysosomal system (ELS), autophagy, and ubiquitin-proteasome system (UPS) are cellular degradation pathways that each play a critical role in the removal ofmisfolded proteins and the prevention of the accumulation of abnormal proteins. Recent studies on Alzheimer's disease (AD) pathogenesis have suggested that accumulation of aggregated β-amyloid (Ab) peptides in the AD brain results from a dysfunction in these cellular clearance systems. However, the specific roles of these pathways in the removal of Ab peptides and the pathogenesis underlying AD are unclear. Our in vitro and in vivo genetic approaches revealed that ELS mainly removed monomeric β-amyloid42 (Aβ42), while autophagy and UPS clear oligomeric Aβ42. Although overproduction of phosphatidylinositol 4-phosphate-5 increased Aβ42 clearance, it reduced the life span of Aβ42 transgenic flies. Our behavioral studies further demonstrated impaired autophagy and UPS-enhanced Aβ42- induced learning and memory deficits, but there was no effect on Aβ42-induced reduction in life span. Results from genetic fluorescence imaging showed that these pathways were damaged in the following order: UPS, autophagy, and finally ELS. The results of our study demonstrate that different degradation pathways play distinct roles inthe removal ofAβ42 aggregates andindisease progression.These findings alsosuggest thatpharmacologic treatments that are designed to stimulate cellular degradation pathways in patients with AD should be used with caution.

UR - http://www.scopus.com/inward/record.url?scp=85043507148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043507148&partnerID=8YFLogxK

U2 - 10.1096/fj.201700199RR

DO - 10.1096/fj.201700199RR

M3 - Article

C2 - 29127191

AN - SCOPUS:85043507148

VL - 32

SP - 1375

EP - 1387

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -